IMNM
Immunome Inc
19.30$
-8.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
Immunome Inc (IMNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.3 | -2.3 | -2.4 | -2.6 | -2.1 | -1.5 | -2.5 | -6.1 | -3.5 | -3.7 | -4.1 | -6.8 | -6.4 | -8.1 | -7.6 | -6.7 | 24 | -5.7 | -8.6 | -17 | -11 | -23 | -34 | -42 | -53 | -49 | -41 | -48 | -59 | -62 | -209 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 1.2 | 3.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.3 | 0.3 | 0.7 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.4 | 1.2 | 1.0 | 1.1 | 2.9 | 2.2 | 3.2 | 4.9 | 5.5 | 5.7 | 5.3 | 6.7 | 7.9 | 8.0 | 8.8 | 31 | |
| – | – | 0.0 | 0.0 | 0.1 | 0.1 | 5.7 | 0.3 | 0.3 | 0.2 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.4 | 1.2 | 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.1 | -0.1 | 0.2 | 0.2 | 0.3 | 0.5 | 0.0 | -2.6 | -0.1 | 1.1 | 2.1 | -0.3 | 3.8 | -0.6 | -0.5 | -0.5 | 27 | -1.3 | -5.9 | -7.9 | 4.5 | 2.9 | 2.2 | 5.3 | -17 | -12 | 10 | 3.2 | -14 | 1.9 | 1.9 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.0 | 0.3 | 2.2 | 2.3 | 1.5 | 1.4 | 3.7 | 0.9 | 1.1 | 4.0 | 3.0 | 2.2 | 10 | |
| 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | -0.4 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.1 | -0.1 | -0.1 | -0.3 | 0.0 | -30 | -37 | -82 | 24 | 9.8 | 5.1 | -64 | 124 | -4.0 | -12 | -304 | -196 | |
| – | – | – | – | – | – | – | 0.0 | 0.1 | 28 | 0.7 | – | – | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | 0.0 | -3.5 | -0.2 | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.2 | 3.2 | 0.0 | 4.4 | 0.8 | 10 | -0.4 | 39 | 0.1 | 27 | 0.6 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 61 | 55 | 219 | 0.7 | 0.3 | 20 | 162 | -0.1 | 45 | 433 | -0.1 | 1.1 | 479 | |
| 0.8 | 0.8 | -2.5 | 1.8 | -1.3 | 8.5 | -3.0 | 33 | -3.5 | 24 | -3.6 | -7.0 | -6.4 | -8.2 | -7.6 | -6.8 | 24 | -6.0 | 52 | 8.0 | 171 | -104 | -9.8 | -12 | 114 | -114 | 129 | 381 | -71 | -365 | 74 | |
| -2.4 | -2.4 | -2.5 | -2.6 | -2.1 | -1.8 | -2.7 | -6.1 | -3.6 | -3.7 | -4.2 | -6.8 | -6.4 | -8.2 | -7.6 | -6.8 | 24 | -6.0 | -8.7 | -18 | -13 | -26 | -36 | -43 | -57 | -50 | -42 | -52 | -62 | -64 | -219 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.